Meridian Bioscience Inc. ( VIVO ) will begin trading ex-dividend on February 04, 2016. A cash dividend payment of $0.2 per share is scheduled to be paid on February 18, 2016. Shareholders who purchased VIVO prior to the ex-dividend date are eligible for the cash dividend payment. This marks the 9th quarter that VIVO has paid the same dividend.
The previous trading day's last sale of VIVO was $18.55, representing a -12.62% decrease from the 52 week high of $21.23 and a 11.75% increase over the 52 week low of $16.60.
VIVO is a part of the Health Care sector, which includes companies such as IDEXX Laboratories, Inc. ( IDXX ) and Alere Inc. ( ALR ). VIVO's current earnings per share, an indicator of a company's profitability, is $.85. Zacks Investment Research reports VIVO's forecasted earnings growth in 2016 as 4.31%, compared to an industry average of 12.2%.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.